<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37897007</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Attenuating RNA Viruses with Expanded Genetic Codes to Evoke Adjustable Immune Response in PylRS-tRNACUAPyl Transgenic Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1606</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines11101606</ELocationID><Abstract><AbstractText>Ribonucleic acid (RNA) viruses pose heavy burdens on public-health systems. Synthetic biology holds great potential for artificially controlling their replication, a strategy that could be used to attenuate infectious viruses but is still in the exploratory stage. Herein, we used the genetic-code expansion technique to convert Enterovirus 71 (EV71), a prototypical RNA virus, into a controllable EV71 strain carrying the unnatural amino acid (UAA) Nε-2-azidoethyloxycarbonyl-L-lysine (NAEK), which we termed an EV71-NAEK virus. After NAEK supplementation, EV71-NAEK could recapitulate an authentic NAEK time- and dose-dependent infection in vitro, which could serve as a novel method to manipulate virulent viruses in conventional laboratories. We further validated the prophylactic effect of EV71-NAEK in two mouse models. In susceptible parent mice, vaccination with EV71-NAEK elicited a strong immune response and protected their neonatal offspring from lethal challenges similar to that of commercial vaccines. Meanwhile, in transgenic mice harboring a PylRS-tRNACUAPyl pair, substantial elements of genetic-code expansion technology, EV71-NAEK evoked an adjustable neutralizing-antibody response in a strictly external NAEK dose-dependent manner. These findings suggested that EV71-NAEK could be the basis of a feasible immunization program for populations with different levels of immunity. Moreover, we expanded the strategy to generate controllable coxsackieviruses for conceptual verification. In combination, these results could underlie a competent strategy for attenuating viruses and priming the immune system via artificial control, which might be a promising direction for the development of amenable vaccine candidates and be broadly applied to other RNA viruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhetao</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-8383-3010</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xuesheng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-8136-1446</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hongmin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yuxuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yuelin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">defective interfering particles</Keyword><Keyword MajorTopicYN="N">genetic code expansion</Keyword><Keyword MajorTopicYN="N">replication-incompetent virus</Keyword><Keyword MajorTopicYN="N">virus engineering</Keyword><Keyword MajorTopicYN="N">virus evolution</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37897007</ArticleId><ArticleId IdType="pmc">PMC10610612</ArticleId><ArticleId IdType="doi">10.3390/vaccines11101606</ArticleId><ArticleId IdType="pii">vaccines11101606</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baltimore D. Expression of Animal Virus Genomes. Bacteriol. Rev. 1971;35:235–241. doi: 10.1128/br.35.3.235-241.1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/br.35.3.235-241.1971</ArticleId><ArticleId IdType="pmc">PMC378387</ArticleId><ArticleId IdType="pubmed">4329869</ArticleId></ArticleIdList></Reference><Reference><Citation>Koff W.C., Burton D.R., Johnson P.R., Walker B.D., King C.R., Nabel G.J., Ahmed R., Bhan M.K., Plotkin S.A. Accelerating Next-Generation Vaccine Development for Global Disease Prevention. Science. 2013;340:1232910. doi: 10.1126/science.1232910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232910</ArticleId><ArticleId IdType="pmc">PMC4026248</ArticleId><ArticleId IdType="pubmed">23723240</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanh Le T., Andreadakis Z., Kumar A., Gómez Román R., Tollefsen S., Saville M., Mayhew S. The COVID-19 Vaccine Development Landscape. Nat. Rev. Drug Discov. 2020;19:305–306. doi: 10.1038/d41573-020-00073-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41573-020-00073-5</ArticleId><ArticleId IdType="pubmed">32273591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lurie N., Saville M., Hatchett R., Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N. Engl. J. Med. 2020;382:1969–1973. doi: 10.1056/NEJMp2005630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2005630</ArticleId><ArticleId IdType="pubmed">32227757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketzer P., Kaufmann J.K., Engelhardt S., Bossow S., von Kalle C., Hartig J.S., Ungerechts G., Nettelbeck D.M. Artificial Riboswitches for Gene Expression and Replication Control of DNA and RNA Viruses. Proc. Natl. Acad. Sci. USA. 2014;111:E554–E562. doi: 10.1073/pnas.1318563111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318563111</ArticleId><ArticleId IdType="pmc">PMC3918795</ArticleId><ArticleId IdType="pubmed">24449891</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung H.K., Jacobs C.L., Huo Y., Yang J., Krumm S.A., Plemper R.K., Tsien R.Y., Lin M.Z. Tunable and Reversible Drug Control of Protein Production via a Self-Excising Degron. Nat. Chem. Biol. 2015;11:713–720. doi: 10.1038/nchembio.1869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1869</ArticleId><ArticleId IdType="pmc">PMC4543534</ArticleId><ArticleId IdType="pubmed">26214256</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahara M., Takishima Y., Miyamoto S., Nakatsu Y., Someya K., Sato M., Tani K., Takeda M. Photocontrollable Mononegaviruses. Proc. Natl. Acad. Sci. USA. 2019;116:11587–11589. doi: 10.1073/pnas.1906531116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1906531116</ArticleId><ArticleId IdType="pmc">PMC6575177</ArticleId><ArticleId IdType="pubmed">31138700</ArticleId></ArticleIdList></Reference><Reference><Citation>Heilmann E., Kimpel J., Hofer B., Rössler A., Blaas I., Egerer L., Nolden T., Urbiola C., Kräusslich H.G., Wollmann G., et al. Chemogenetic ON and OFF Switches for RNA Virus Replication. Nat. Commun. 2021;12:1362. doi: 10.1038/s41467-021-21630-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21630-5</ArticleId><ArticleId IdType="pmc">PMC7921684</ArticleId><ArticleId IdType="pubmed">33649317</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeyanathan M., Afkhami S., Smaill F., Miller M.S., Lichty B.D., Xing Z. Immunological Considerations for COVID-19 Vaccine Strategies. Nat. Rev. Immunol. 2020;20:615–632. doi: 10.1038/s41577-020-00434-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00434-6</ArticleId><ArticleId IdType="pmc">PMC7472682</ArticleId><ArticleId IdType="pubmed">32887954</ArticleId></ArticleIdList></Reference><Reference><Citation>Excler J.-L., Saville M., Berkley S., Kim J.H. Vaccine Development for Emerging Infectious Diseases. Nat. Med. 2021;27:591–600. doi: 10.1038/s41591-021-01301-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01301-0</ArticleId><ArticleId IdType="pubmed">33846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Thi Nhu Thao T., Labroussaa F., Ebert N., V’kovski P., Stalder H., Portmann J., Kelly J., Steiner S., Holwerda M., Kratzel A., et al. Rapid Reconstruction of SARS-CoV-2 Using a Synthetic Genomics Platform. Nature. 2020;582:561–565. doi: 10.1038/s41586-020-2294-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2294-9</ArticleId><ArticleId IdType="pubmed">32365353</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., Muruato A., Lokugamage K.G., Narayanan K., Zhang X., Zou J., Liu J., Schindewolf C., Bopp N.E., Aguilar P.V., et al. An Infectious CDNA Clone of SARS-CoV-2. Cell Host Microbe. 2020;27:841–848.e3. doi: 10.1016/j.chom.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7153529</ArticleId><ArticleId IdType="pubmed">32289263</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam P.S., Scott M.K.D., Hagan T., Li C., Feng Y., Wimmers F., Grigoryan L., Trisal M., Edara V.V., Lai L., et al. Systems Vaccinology of the BNT162b2 MRNA Vaccine in Humans. Nature. 2021;596:410–416. doi: 10.1038/s41586-021-03791-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03791-x</ArticleId><ArticleId IdType="pmc">PMC8761119</ArticleId><ArticleId IdType="pubmed">34252919</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho A., Muecksch F., Schaefer-Babajew D., Wang Z., Finkin S., Gaebler C., Ramos V., Cipolla M., Mendoza P., Agudelo M., et al. Anti-SARS-CoV-2 Receptor Binding Domain Antibody Evolution after MRNA Vaccination. Nature. 2021;600:517–522. doi: 10.1038/s41586-021-04060-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04060-7</ArticleId><ArticleId IdType="pmc">PMC8674133</ArticleId><ArticleId IdType="pubmed">34619745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin J.W., Cropp T.A., Anderson J.C., Mukherji M., Zhang Z., Schultz P.G. An Expanded Eukaryotic Genetic Code. Science. 2003;301:964–967. doi: 10.1126/science.1084772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1084772</ArticleId><ArticleId IdType="pubmed">12920298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Brock A., Herberich B., Schultz P.G. Expanding the Genetic Code of Escherichia Coli. Science. 2001;292:498–500. doi: 10.1126/science.1060077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1060077</ArticleId><ArticleId IdType="pubmed">11313494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N., Li Y., Niu W., Sun M., Cerny R., Li Q., Guo J. Construction of a Live-Attenuated HIV-1 Vaccine through Genetic Code Expansion. Angew. Chem. Int. Ed. 2014;53:4867–4871. doi: 10.1002/anie.201402092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201402092</ArticleId><ArticleId IdType="pmc">PMC4984542</ArticleId><ArticleId IdType="pubmed">24715496</ArticleId></ArticleIdList></Reference><Reference><Citation>Si L., Xu H., Zhou X., Zhang Z., Tian Z., Wang Y., Wu Y., Zhang B., Niu Z., Zhang C., et al. Generation of Influenza A Viruses as Live but Replication-Incompetent Virus Vaccines. Science. 2016;354:1170–1173. doi: 10.1126/science.aah5869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah5869</ArticleId><ArticleId IdType="pubmed">27934767</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi N., Yang Q., Zhang H., Lu J., Lin H., Yang X., Abulimiti A., Cheng J., Wang Y., Tong L., et al. Restoration of Dystrophin Expression in Mice by Suppressing a Nonsense Mutation through the Incorporation of Unnatural Amino Acids. Nat. Biomed. Eng. 2021;6:195–206. doi: 10.1038/s41551-021-00774-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-021-00774-1</ArticleId><ArticleId IdType="pubmed">34341535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wan Y., Wang N., Yuan Z., Niu W., Li Q., Guo J. Controlling the Replication of a Genomically Recoded HIV-1 with a Functional Quadruplet Codon in Mammalian Cells. ACS Synth. Biol. 2018;7:1612–1617. doi: 10.1021/acssynbio.8b00096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acssynbio.8b00096</ArticleId><ArticleId IdType="pmc">PMC6003876</ArticleId><ArticleId IdType="pubmed">29787233</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Liu Y., Liu J., Bailey A.L., Plante K.S., Plante J.A., Zou J., Xia H., Bopp N.E., Aguilar P.V., et al. A Trans-Complementation System for SARS-CoV-2 Recapitulates Authentic Viral Replication without Virulence. Cell. 2021;184:2229–2238.e13. doi: 10.1016/j.cell.2021.02.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.044</ArticleId><ArticleId IdType="pmc">PMC7901297</ArticleId><ArticleId IdType="pubmed">33691138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricardo-Lax I., Luna J.M., Thao T.T.N., Le Pen J., Yu Y., Hoffmann H.-H., Schneider W.M., Razooky B.S., Fernandez-Martinez J., Schmidt F., et al. Replication and Single-Cycle Delivery of SARS-CoV-2 Replicons. Science. 2021;374:1099–1106. doi: 10.1126/science.abj8430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj8430</ArticleId><ArticleId IdType="pmc">PMC9007107</ArticleId><ArticleId IdType="pubmed">34648371</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard A.J., Bijker E.M. A Guide to Vaccinology: From Basic Principles to New Developments. Nat. Rev. Immunol. 2021;21:83–100. doi: 10.1038/s41577-020-00479-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00479-7</ArticleId><ArticleId IdType="pmc">PMC7754704</ArticleId><ArticleId IdType="pubmed">33353987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical Features, Diagnosis, and Management of Enterovirus 71. Lancet Neurol. 2010;9:1097–1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, Epidemiology, Pathogenesis, and Control of Enterovirus 71. Lancet Infect. Dis. 2010;10:778–790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao R., Ma K., Ru Y., Li D., Song G., Lu B., Liu H., Li Y., Zhang J., Wu C., et al. Amber Codon Is Genetically Unstable in Generation of Premature Termination Codon (PTC)-Harbouring Foot-and-Mouth Disease Virus (FMDV) via Genetic Code Expansion. RNA Biol. 2021;18:2330–2341. doi: 10.1080/15476286.2021.1907055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2021.1907055</ArticleId><ArticleId IdType="pmc">PMC8632096</ArticleId><ArticleId IdType="pubmed">33849391</ArticleId></ArticleIdList></Reference><Reference><Citation>Roehl H.H., Parsley T.B., Ho T.V., Semler B.L. Processing of a Cellular Polypeptide by 3CD Proteinase Is Required for Poliovirus Ribonucleoprotein Complex Formation. J. Virol. 1997;71:578–585. doi: 10.1128/jvi.71.1.578-585.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.1.578-585.1997</ArticleId><ArticleId IdType="pmc">PMC191087</ArticleId><ArticleId IdType="pubmed">8985386</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown W., Liu J., Deiters A. Genetic Code Expansion in Animals. ACS Chem. Biol. 2018;13:2375–2386. doi: 10.1021/acschembio.8b00520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.8b00520</ArticleId><ArticleId IdType="pmc">PMC7026698</ArticleId><ArticleId IdType="pubmed">30125487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin J.W. Expanding and Reprogramming the Genetic Code of Cells and Animals. Annu. Rev. Biochem. 2014;83:379–408. doi: 10.1146/annurev-biochem-060713-035737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060713-035737</ArticleId><ArticleId IdType="pubmed">24555827</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Ma J., Lu W., Tian M., Thauvin M., Yuan C., Volovitch M., Wang Q., Holst J., Liu M., et al. Heritable Expansion of the Genetic Code in Mouse and Zebrafish. Cell Res. 2017;27:294–297. doi: 10.1038/cr.2016.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2016.145</ArticleId><ArticleId IdType="pmc">PMC5339847</ArticleId><ArticleId IdType="pubmed">27934867</ArticleId></ArticleIdList></Reference><Reference><Citation>ElSohly A.M., MacDonald J.I., Hentzen N.B., Aanei I.L., El Muslemany K.M., Francis M.B. Ortho-Methoxyphenols as Convenient Oxidative Bioconjugation Reagents with Application to Site-Selective Heterobifunctional Cross-Linkers. J. Am. Chem. Soc. 2017;139:3767–3773. doi: 10.1021/jacs.6b12966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.6b12966</ArticleId><ArticleId IdType="pubmed">28207247</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens C.R., Hooker J.M., Obermeyer A.C., Romanini D.W., Katz E.M., Francis M.B. Rapid Chemoselective Bioconjugation through Oxidative Coupling of Anilines and Aminophenols. J. Am. Chem. Soc. 2011;133:16398–16401. doi: 10.1021/ja2033298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja2033298</ArticleId><ArticleId IdType="pmc">PMC3389565</ArticleId><ArticleId IdType="pubmed">21919497</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson S.B., Mukherjee R., Kelemen R.E., Wrobel C.J.J., Cao X., Chatterjee A. Precise Photoremovable Perturbation of a Virus–Host Interaction. Angew. Chem. Int. Ed. 2017;56:4234–4237. doi: 10.1002/anie.201700683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201700683</ArticleId><ArticleId IdType="pubmed">28294501</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Yu F., Wu Y., Si L., Xu H., Zhang C., Xia Q., Xiao S., Wang Q., He Q., et al. Broadening the Versatility of Lentiviral Vectors as a Tool in Nucleic Acid Research via Genetic Code Expansion. Nucleic Acids Res. 2015;43:e73. doi: 10.1093/nar/gkv202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv202</ArticleId><ArticleId IdType="pmc">PMC4477642</ArticleId><ArticleId IdType="pubmed">25765642</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakin V., Hanne J., Dunder J., Anders-Össwein M., Laketa V., Nikić I., Kräusslich H.-G., Lemke E.A., Müller B. A Versatile Tool for Live-Cell Imaging and Super-Resolution Nanoscopy Studies of HIV-1 Env Distribution and Mobility. Cell Chem. Biol. 2017;24:635–645.e5. doi: 10.1016/j.chembiol.2017.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2017.04.007</ArticleId><ArticleId IdType="pubmed">28457706</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikić I., Plass T., Schraidt O., Szymański J., Briggs J.A.G., Schultz C., Lemke E.A. Minimal Tags for Rapid Dual-Color Live-Cell Labeling and Super-Resolution Microscopy. Angew. Chem. Int. Ed. 2014;53:2245–2249. doi: 10.1002/anie.201309847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201309847</ArticleId><ArticleId IdType="pubmed">24474648</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Xue P., Cao M., Yu T., Lane S.T., Zhao H. Directed Evolution: Methodologies and Applications. Chem. Rev. 2021;121:12384–12444. doi: 10.1021/acs.chemrev.1c00260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.1c00260</ArticleId><ArticleId IdType="pubmed">34297541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiesslich S., Kamen A.A. Vero Cell Upstream Bioprocess Development for the Production of Viral Vectors and Vaccines. Biotechnol. Adv. 2020;44:107608. doi: 10.1016/j.biotechadv.2020.107608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biotechadv.2020.107608</ArticleId><ArticleId IdType="pmc">PMC7405825</ArticleId><ArticleId IdType="pubmed">32768520</ArticleId></ArticleIdList></Reference><Reference><Citation>Young D.D., Schultz P.G. Playing with the Molecules of Life. ACS Chem. Biol. 2018;13:854–870. doi: 10.1021/acschembio.7b00974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.7b00974</ArticleId><ArticleId IdType="pmc">PMC6061972</ArticleId><ArticleId IdType="pubmed">29345901</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelemen R.E., Mukherjee R., Cao X., Erickson S.B., Zheng Y., Chatterjee A. A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus. Angew. Chem. Int. Ed. 2016;55:10645–10649. doi: 10.1002/anie.201604067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201604067</ArticleId><ArticleId IdType="pubmed">27483453</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao T., Zhou X., Zhang C., Yu X., Tian Z., Zhang L., Zhou D. Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity. Molecules. 2017;22:1155. doi: 10.3390/molecules22071155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules22071155</ArticleId><ArticleId IdType="pmc">PMC6152081</ArticleId><ArticleId IdType="pubmed">28696391</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary N., Weissman D., Whitehead K.A. MRNA Vaccines for Infectious Diseases: Principles, Delivery and Clinical Translation. Nat. Rev. Drug Discov. 2021;20:817–838. doi: 10.1038/s41573-021-00283-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00283-5</ArticleId><ArticleId IdType="pmc">PMC8386155</ArticleId><ArticleId IdType="pubmed">34433919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewnard J.A., Lo N.C., Arinaminpathy N., Frost I., Laxminarayan R. Childhood Vaccines and Antibiotic Use in Low- and Middle-Income Countries. Nature. 2020;581:94–99. doi: 10.1038/s41586-020-2238-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2238-4</ArticleId><ArticleId IdType="pmc">PMC7332418</ArticleId><ArticleId IdType="pubmed">32376956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan M.J., Lyke K.E., Kitchin N., Absalon J., Gurtman A., Lockhart S., Neuzil K., Raabe V., Bailey R., Swanson K.A., et al. Phase I/II Study of COVID-19 RNA Vaccine BNT162b1 in Adults. Nature. 2020;586:589–593. doi: 10.1038/s41586-020-2639-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2639-4</ArticleId><ArticleId IdType="pubmed">32785213</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagan N., Barda N., Biron-Shental T., Makov-Assif M., Key C., Kohane I.S., Hernán M.A., Lipsitch M., Hernandez-Diaz S., Reis B.Y., et al. Effectiveness of the BNT162b2 MRNA COVID-19 Vaccine in Pregnancy. Nat. Med. 2021;27:1693–1695. doi: 10.1038/s41591-021-01490-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01490-8</ArticleId><ArticleId IdType="pubmed">34493859</ArticleId></ArticleIdList></Reference><Reference><Citation>Cubillos-Ruiz A., Guo T., Sokolovska A., Miller P.F., Collins J.J., Lu T.K., Lora J.M. Engineering Living Therapeutics with Synthetic Biology. Nat. Rev. Drug Discov. 2021;20:941–960. doi: 10.1038/s41573-021-00285-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00285-3</ArticleId><ArticleId IdType="pubmed">34616030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>